Autopsy report · NCT01122719
Brazilian and Italian Evaluation of Safety Using Tacrolimus-eluting Stent With Short-term Dual Antiplatelet Regimen
Cause of deathSlow enrollment
“slow inclusion, due to difficulties in obtaining the patients consent for the 2 months invasive follow-up, as required by protocol design.”
Life of this trial
- Registered 5 months before it started.
- Ran for about 2 years 5 months before it stopped.
- 16 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Na
- Sponsor
- CID - Carbostent & Implantable Devices
- Sponsor type
- Industry
- Conditions
- Stable Coronary Disease; Unstable Coronary Disease; Documented Silent Ischemia
- Interventions
- Drug Eluting Stent
- Participants
- 16
- Sites
- 2
- Countries
- Brazil, Italy
Trials that died the same way
- Long-term Treatment for Cancer Patients With Deep Venous Thrombosis or Pulmonary Embolism
“Due to slow inclusion of patients” - Exercise for Improving Prostate Oxygenation in Prostate Tumors (Exipox)
“Slow inclusion rate due to patients operated before intervention is implementable” - Developing a Self-persuasion Intervention Promoting Adolescent HPV Vaccination: Feasibility Trial
“Halted early due to poor accrual and lack of time to receive intervention procedures adjacent to a clinic visit post randomization.” - Deferasirox in Treating Patients With Iron Overload After Undergoing a Donor Stem Cell Transplant
“Due to slow accrual of patients” - Cooling the Uterus in C-section After Dysfunctional Labor
“Difficulty in acquiring patients in a reasonable amount of time.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.